NCT05642936

Brief Summary

This was a randomized, single-blind, controlled, community-based trial comparing the clinical efficacy of the Transcendental Meditation program on carotid intima-media thickness and major adverse cardiovascular events in 197 African American men and women at risk for atherosclerotic CVD. After baseline testing, participants were randomly assigned to either a stress reduction program (Transcendental Meditation) or a standard health education program. Follow up was conducted over one year and 12 years.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
197

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2000

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2000

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2005

Completed
9.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2014

Completed
7.9 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

4.8 years

First QC Date

November 30, 2022

Last Update Submit

May 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Carotid Intima Medial Thickness (CIMT)

    This measure of wall thickness of the carotid artery was assessed by B-mode ultrasonography

    12 months

Secondary Outcomes (5)

  • blood pressure

    baseline, 3 and 12 months

  • lipid profile

    baseline and 12 months

  • lifestyle factors

    baseline, 3 and 12 months

  • major adverse cardiovascular events (MACE) - fatal and nonfatal

    one year

  • major adverse cardiovascular events (MACE) - fatal

    12 years

Study Arms (2)

Transcendental Meditation

EXPERIMENTAL

The TM technique is a simple, natural, effortless mental procedure that is practiced 20 minutes twice a day while sitting comfortably with the eyes closed. During the practice, it is reported that ordinary thinking processes settle down, and a distinctive "wakeful hypometabolic" state characterized by neural coherence and physiological rest is gained. The TM technique was taught in a 7-step course of instruction consisting of six 1.5-2 hour individual and group meetings taught by a certified instructor.

Behavioral: Transcendental Meditation technique

Health Education

ACTIVE COMPARATOR

The control intervention was a cardiovascular health education program designed to match the format of the experimental intervention for instructional time, instructor attention, participant expectancy, social support, and other nonspecific factors. The classroom content was based on standard, published materials. The instructors were professional health educators.

Behavioral: didactic health education control

Interventions

didactic classroom-based comparison group that follows standard guidelines for diet, exercise and substance use with no stress reduction component

Also known as: lifestyle modification
Health Education

a mental technique derived from the Vedic tradition of ancient India and practiced by anyone for 20 minutes twice a day sitting

Also known as: TM program
Transcendental Meditation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • race/ethnicity: African American, self-identified, age: no upper limit, gender: male or female, minimum carotid artery intima medial thickness (IMT) of at least .72 mm for men and .65 mm for women or long-term history of diabetes, myocardial infarction, coronary artery revascularization or coronary angiography indicating at least one vessel with 50% stenosis.

You may not qualify if:

  • myocardial infarction, unstable angina, CABG, percutaneous transluminal coronary angioplasty (PTCA), or stroke within the previous three months, carotid artery endarterectomy, arrhythmia - atrial fibrillation, second or third degree AV block, congestive heart failure - class III or IV or ejection fraction less than 30 %, clinically significant valvular heart disease, clinically significant hepatic or renal failure, major psychiatric disorders, current alcohol or other drug abuse dependency disorder, non-cardiac life-threatening illness, and participating in a formal stress management program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Norris KC, Salerno J, Bairey Merz CN, Kaushik V, Gelleta S, Castillo A, Nidich S, Gaylord-King C, Schneider RH. A randomized controlled trial of meditation and health education on carotid intima-media thickness and major adverse cardiovascular events in Black men and women. Front Med (Lausanne). 2025 Mar 19;12:1513699. doi: 10.3389/fmed.2025.1513699. eCollection 2025.

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Robert H Schneider, M.D.

    Maharishi International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All investigators and clinic staff were blinded to treatment assignment, except the project manager who did not collect data from participants. Primary care physicians were blinded to the treatment assignments of their patients. Since participants were necessarily aware of their treatment status.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This was a randomized controlled community-based clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director and Professor, Institute for Natural Medicine and Prevention

Study Record Dates

First Submitted

November 30, 2022

First Posted

December 8, 2022

Study Start

October 1, 2000

Primary Completion

July 1, 2005

Study Completion

December 31, 2014

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

upon request to the study investigators, an outside researcher may inquire for permission to obtain the IPD (deidentified) on an MS excel and Access databases.

Shared Documents
STUDY PROTOCOL
Time Frame
once the study is published (i.e., in print)